Financing
Net Change in Short-term Borrowings and Indebtedness to Subsidiaries
Eli Lilly Net Change in Short-term Borrowings and Indebtedness to Subsidiaries increased by 443850.0% to $1.78B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 196.0%, from -$1.85B to $1.78B.
Analysis
StatementCash Flow Statement
SectionFinancing
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
Metric ID:
wfc_change_in_short_term_borrowings_and_subsidiary_debtHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.00M | -$1.00M | -$1.00M | $499.70M | $1.62B | -$1.50B | $0.00 | $1.60B | $4.59B | -$5.20B | -$3.09B | -$1.85B | -$4.09B | -$400.00K | $1.78B |
| QoQ Change | — | +0.0% | +0.0% | >999% | +223.7% | -192.6% | +100.0% | — | +188.0% | -213.3% | +40.6% | +40.2% | -121.3% | +100.0% | >999% |
| YoY Change | — | — | — | — | >999% | -399.8% | -100.0% | — | — | -247.4% | -293.7% | +64.5% | -32.4% | — | +196.0% |
Range-$5.20B – $4.59B
CAGR+747.9%
Avg YoY Growth>999%
Median YoY Growth-66.2%
Current Streak2 quarters growth
Net Change in Short-term Borrowings and Indebtedness to Subsidiaries at Other Companies
Frequently Asked Questions
- What is Eli Lilly's net change in short-term borrowings and indebtedness to subsidiaries?
- Eli Lilly (LLY) reported net change in short-term borrowings and indebtedness to subsidiaries of $1.78B in Q1 2026.
- How has Eli Lilly's net change in short-term borrowings and indebtedness to subsidiaries changed year-over-year?
- Eli Lilly's net change in short-term borrowings and indebtedness to subsidiaries increased by 196.0% year-over-year, from -$1.85B to $1.78B.